Bessemer Group Inc Astrazeneca PLC Transaction History

Bessemer Group Inc

  • $61.3 Billion
  • Q4 2024

A detailed history of Bessemer Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Bessemer Group Inc holds 115,187 shares of AZN stock, worth $8.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
115,187
Previous 119,302 3.45%
Holding current value
$8.55 Million
Previous $9.3 Million 18.82%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$63.2 - $79.58 $260,068 - $327,471
-4,115 Reduced 3.45%
115,187 $7.55 Million
Q3 2024

Nov 12, 2024
BUY
$76.67 - $87.62 $137,775 - $157,453
1,797 Added 1.53%
119,302 $9.3 Million
Q2 2024

Aug 13, 2024
BUY
$66.81 - $80.83 $1.49 Million - $1.8 Million
22,244 Added 23.35%
117,505 $9.16 Million
Q1 2024

May 13, 2024
SELL
$61.03 - $69.57 $791,742 - $902,531
-12,973 Reduced 11.99%
95,261 $6.45 Million
Q4 2023

Feb 09, 2024
BUY
$61.89 - $69.28 $50,749 - $56,809
820 Added 0.76%
108,234 $7.29 Million
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $717,630 - $793,432
-11,066 Reduced 9.34%
107,414 $7.28 Million
Q2 2023

Aug 10, 2023
BUY
$69.91 - $75.81 $2.84 Million - $3.08 Million
40,670 Added 52.27%
118,480 $8.48 Million
Q1 2023

May 10, 2023
BUY
$63.15 - $71.6 $476,782 - $540,580
7,550 Added 10.75%
77,810 $5.4 Million
Q4 2022

Feb 13, 2023
SELL
$54.21 - $70.44 $192,499 - $250,132
-3,551 Reduced 4.81%
70,260 $4.76 Million
Q3 2022

Nov 09, 2022
BUY
$53.02 - $135.75 $802,245 - $2.05 Million
15,131 Added 25.79%
73,811 $4.05 Million
Q2 2022

Aug 10, 2022
BUY
$59.26 - $71.14 $2.26 Million - $2.71 Million
38,124 Added 185.46%
58,680 $3.88 Million
Q1 2022

May 12, 2022
SELL
$55.72 - $67.12 $20,950 - $25,237
-376 Reduced 1.8%
20,556 $1.36 Million
Q4 2021

Jan 27, 2022
BUY
$54.02 - $63.83 $248,059 - $293,107
4,592 Added 28.1%
20,932 $1.22 Million
Q3 2021

Nov 12, 2021
BUY
$55.56 - $60.79 $329,248 - $360,241
5,926 Added 56.9%
16,340 $982,000
Q2 2021

Aug 06, 2021
BUY
$48.42 - $60.18 $138,674 - $172,355
2,864 Added 37.93%
10,414 $623,000
Q1 2021

May 13, 2021
BUY
$47.16 - $54.44 $136,339 - $157,386
2,891 Added 62.05%
7,550 $375,000
Q4 2020

Feb 09, 2021
BUY
$48.52 - $58.02 $65,016 - $77,746
1,340 Added 40.37%
4,659 $233,000
Q2 2020

Aug 05, 2020
SELL
$43.1 - $55.31 $160,590 - $206,085
-3,726 Reduced 52.89%
3,319 $176,000
Q1 2020

Apr 30, 2020
BUY
$37.79 - $51.33 $18,706 - $25,408
495 Added 7.56%
7,045 $315,000
Q4 2019

Feb 04, 2020
BUY
$42.46 - $50.46 $36,812 - $43,748
867 Added 15.26%
6,550 $326,000
Q3 2019

Nov 07, 2019
BUY
$40.12 - $45.47 $36,027 - $40,832
898 Added 18.77%
5,683 $253,000
Q2 2019

Jul 19, 2019
BUY
$37.28 - $41.68 $57,523 - $64,312
1,543 Added 47.59%
4,785 $198,000
Q1 2019

May 13, 2019
SELL
$35.49 - $43.02 $173,084 - $209,808
-4,877 Reduced 60.07%
3,242 $131,000
Q4 2018

Feb 12, 2019
BUY
$36.86 - $41.49 $7,040 - $7,924
191 Added 2.41%
8,119 $308,000
Q3 2018

Nov 06, 2018
BUY
$34.76 - $39.72 $113,908 - $130,162
3,277 Added 70.46%
7,928 $313,000
Q2 2018

Jul 25, 2018
BUY
$34.55 - $37.05 $62,880 - $67,431
1,820 Added 64.29%
4,651 $163,000
Q1 2018

May 10, 2018
SELL
$32.97 - $36.63 $46,916 - $52,124
-1,423 Reduced 33.45%
2,831 $99,000
Q4 2017

Jan 30, 2018
SELL
$32.09 - $34.78 $90,814 - $98,427
-2,830 Reduced 39.95%
4,254 $148,000
Q3 2017

Nov 03, 2017
BUY
$28.96 - $34.0 $205,152 - $240,856
7,084
7,084 $240,000

Others Institutions Holding AZN

# of Institutions
1,355
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $230B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email